ribociclib
novartis
['bcsm']
#maintain- endocrine thpy switch w/ or w/out ribo after progression on prior et+cdk. hr of 0.57 pfs 2.7 mo et alone vs. 5.2 mo w/ ribo persists whether getting steroidal ai or fulvestrant as et backbone #asco22 #bcsm 
Med Onc, Director of Breast & GYN Research Program @ Sarah Cannon Research Institute #bcsm #gyncsm #WomenInMedicine USAF Wife, Mom to 2 girls, tweets are mine.